Case Report: Durable complete response of metastatic hepatocellular carcinoma with asymptomatic hyperamylasemia to combined immunotherapy of anti-cytotoxic T lymphocyte-associated antigen 4 plus anti-programmed cell death-1 antibodies

BACKGROUND: Combined immunotherapy has shown promising results in the treatment of advanced HCC, whereas the priority population that would respond to the combined immunotherapy is still elusive. In addition, HCC with asymptomatic hyperamylasemia was not reported previously. CASE PRESENTATION: An ag...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Han, Chang, Rui-zhi, Chen, Xiao-ping, Zhang, Wan-guang, Zhang, Bixiang, Luo, Xin, Ding, Ze-yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587582/
https://www.ncbi.nlm.nih.gov/pubmed/37869012
http://dx.doi.org/10.3389/fimmu.2023.1274449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587582/
https://www.ncbi.nlm.nih.gov/pubmed/37869012
http://dx.doi.org/10.3389/fimmu.2023.1274449

Ejemplares similares